The Mucopolysaccharidoses

Lysosomal Storage Disorders: A Practical Guide

Volumn , Issue , 2012, Pages 94-100

  Giugliani, Roberto ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Bone dysplasia; Bone Marrow Transplantation (BMT); Gene therapy; Glycosaminoglycans (GAGs); Mucopolysaccharidoses (MPSs)

Indexed keywords

EID: 84886522673     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118514672.ch12     Document Type: Chapter

References (17)

1. Beck M. Therapy for lysosomal storage disorders. IUBMB Life, 2010;62(1):33-40.
2. Clarke LA. The mucopolysaccharidoses: a success of molecular medicine. Expert Rev Mol Med 2008;18:10e1.
3. Giugliani R, Federhen A, Rojas MV, et al. Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment. Genet Mol Biol 2010;33(4):589-604.
4. Giugliani R, Harmatz P, Wraith JE. Management guidelines for mucopolysaccharidosis VI. Pediatrics 2007;120(2):405-418.
5. Hendriksz C. Improved diagnostic procedures in attenuated mucopolysaccharidosis. Br J Hosp Med (Lond) 2011;72(2):91-95.
6. Martin R, Beck M, Eng C, et al. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). Pediatrics 2008;121(2): e377-386.
7. Mendelsohn NJ, Harmatz P, Bodamer O, et al. Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome Survey. Genet Med 2010;12(12):816-822.
8. Muenzer J. The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations. J Pediatr 2004;5 (Suppl): S27-34.
9. Muenzer J, Beck M, Eng CM, et al. Multidisciplinary management of Hunter syndrome. Pediatrics 2009;124(6): e1228-1239.
10. Muenzer J, Wraith JE, Clarke LA. Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 2009;123(1):19-29.
11. Ponder KP, Haskins ME. Gene therapy for mucopolysaccharidosis. Expert Opin Biol Ther 2011;7:1333-1345.
12. Prasad VK, Kurtzberg J. Transplant outcomes in mucopolysaccharidoses. Semin Hematol 2010;47(1):59-69.
13. Pinto LLC, Viera TAV, Giugliani R, Schwartz IVD. Expression of the disease on female carriers of X-linked Lysosomal disorders: a brief review. Orphanet J Rare Dis 2010;5:14.
14. de Ru MH, Boelens JJ, Das AM, et al. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis 2011;6:55.
15. Tomatsu S, Montaño AM, Oikawa H, et al. Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment. Curr Pharm Biotechnol 2011;12(6):931-945.
16. Wegrzyn G, Jakóbkiewicz-Banecka J, Gabig-Cimińska M, et al. Genistein: a natural isoflavone with a potential for treatment of genetic diseases. Biochem Soc Trans 2010;38(2):695-701.
17. Wraith JE. Enzyme replacement therapy for the management of the mucopolysaccharidoses. Int J Clin Pharmacol Ther 2009;47 (Suppl 1): S63-65.